恶性肿瘤社区随访模式的研究进展

doi:10.11904/j.issn.1002-3070.2020.06.011

Abstract

Abstract: Malignant tumors are important diseases that affect the health of Chinese residents.Community follow-up of malignant tumors is becoming increasingly important for improving patient prognosis and quality of life.This article reviews the relevant research on community malignant tumor follow-up models at home and abroad,expounds the research status,characteristics and forms of community malignant tumor follow-up models,which on this basis,puts forward the consideration of domestic community malignant tumor follow-up models and the implications for practice.

Key words: Community health services, Malignant tumor, Follow-up, Model

CLC Number:

LI Jianxin, SHEN Binjie, WANG Xuan. Research progress of community follow-up model for malignant tumors[J]. Journal of Practical Oncology, 2020, 34(6): 540-543.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2020.06.011

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2020/V34/I6/540

References

1 郑荣寿,孙可欣,张思维,等.2015年中国恶性肿瘤流行情况分析[J].中华肿瘤杂志,2019,1(41):19-28.
2 顾秀瑛,顾晓芬,朱俊宇,等.2014-2016年乌鲁木齐市9265例城市居民肺癌筛查结果分析[J].实用肿瘤学杂志,2017,31(3):242-245.
3 曹广文.社区流行病学研究是探索恶性肿瘤病因和评估预防控制效果的关键[J].上海预防医学,2018,30(2):83-88.
4 Meiklejohn JA,Mimery A,Martin JH,et al.The role of the GP in follow-up cancer care:a systematic literature review[J].J Cancer Surviv,2016,10(6):990-1011.
5 Richards M,Corner J,Maher J.The National Cancer Survivorship Initiative:new and emerging evidence on the ongoing needs of cancer survivors[J].Br J Cancer,2011,105(Suppl 1):1-4.
6 Maher J,Radford G.Addressing future challenges for cancer services:part II[J].Future Oncol,2016,12(4):445-449.
7 Pollack LA,Adamache W,Ryerson AB,et al.Care of long-term cancer survivors:physicians seen by Medicare enrollees surviving longer than 5 years[J].Cancer,2009,115(22):5284-5295.
8 张莹莹,Luo JL.中美两国头颈部肿瘤规范化诊疗差异浅析[J].中国耳鼻咽喉颅底外科杂志,2019,25(1):1-9.
9 Nyarko E,Metz JM,Nguyen GT,et al.Cancer survivors′ perspectives on delivery of survivorship care by primary care physicians:an internet-based survey[J].BMC Fam Pract,2015,16:143.
10 Geramita EM,Parker IR,Brufsky JW,et al.Primary care providers′ knowledge,attitudes,beliefs,and practices regarding their preparedness to provide cancer survivorship care[J].J Cancer Educ,2019[online ahead of print].
11 Sanft T,Denlinger CS,Armenian S,et al.NCCN Guidelines Insights:Survivorship,Version 2.2019[J].J Natl Compr Canc Netw,2019,17(7):784-794.
12 Brouwers MC,Vukmirovic M,Tomasone JR,et al.Documenting coordination of cancer care between primary care providers and oncology specialists in Canada[J].Can Fam Physician,2016,62(10):616-625.
13 Franco BB,Dharmakulaseelan L,McAndrew A,et al.The experiences of cancer survivors while transitioning from tertiary to primary care[J].Curr Oncol,2016,23(6):378-385.
14 Kendell C,Decker KM,Groome PA,et al.Use of physician services during the survivorship phase:a multi-province study of women diagnosed with breast cancer[J].Curr Oncol,2017,24(2):81-89.
15 Young JM,Durcinoska I,DeLoyde K,et al.Patterns of follow up and survivorship care for people with colorectal cancer in new South Wales,Australia:a population-based survey[J].BMC Cancer,2018,18(1):339.
16 Lawn S,Fallon-Ferguson J,Koczwara B.Shared care involving cancer specialists and primary care providers-What do cancer survivors want?[J].Health Expect,2017,20(5):1081-1087.
17 Schütze H,Chin M,Weller D,et al.Patient,general practitioner and oncologist views regarding long-term cancer shared care[J].Fam Pract,2018,35(3):323-329.
18 Poplack DG,Fordis M,Landier W,et al.Childhood cancer survivor care:development of the Passport for Care[J].Nat Rev Cli Oncol,2014,11(12):740-750.
19 Singer S,Gianinazzi ME,Hohn A,et al.General practitioner involvement in follow-up of childhood cancer survivors:a systematic review[J].Pediatr Blood Cancer,2013,60(10):1565-1573.
20 Landier W,Skinner R,Wallace WH,et al.Surveillance for Late Effects in Childhood Cancer Survivors[J].J Clin Oncol,2018,36(21):2216-2222.
21 Haupt R,Essiaf S,Dellacasa C,et al.The ′Survivorship Passport′ for childhood cancer survivors[J].Eur J Cancer,2018,102:69-81.
22 Signorelli C,Wakefield CE,Fardell JE,et al.The role of primary care physicians in childhood cancer survivorship care:multiperspective interviews[J].Oncologist,2019,24(5):710-719.
23 陈万青,梁智恒,岑惠珊,等.中国肿瘤登记现况及发展[J].中国医学前沿杂志(电子版),2016,8(7):1-6.
24 毛凡,姜莹莹,董文兰,等.国家慢性病综合防控示范区建设的效果评价[J].中华流行病学杂志,2017,38(4):496-502.
25 郑莹.上海市肿瘤预防控制工作70年回顾[J].中国卫生资源,2019,22(4):269-289.
26 杨丽萍,赛顺平,刘宗文.社区健康档案干预与肿瘤患者康复治疗的相关性[J].中国老年学杂志,2013,33(10):2390-2391.
27 顾益玮,章璞,刘文娟,等.结合微信群的团体认知行为干预对社区癌症患者生活质量的影响[J].上海预防医学,2018,30(6):487-492.

[1]	WEN Hongmei, CHEN Yang, SHI Qingping, REN Siying, GAO Jiao, QIN Mingfang. Analysis of cancer incidence and mortality in Yunnan cancer registry,2016 [J]. Journal of Practical Oncology, 2020, 34(6): 485-490.
[2]	XIANG Zhisheng, MA Jingyu, ZHONG Wenling, CHEN Tiehui, LIN Yongtian, JIANG Huijuan, ZHOU Yan. Analysis of the incidence and mortality of malignant tumors in Fujian,2016 [J]. Journal of Practical Oncology, 2020, 34(6): 491-494.
[3]	SONG Jiayu, FENG Yue, WANG Zhao, ZHANG Yunyan. The latest research progress of the correlation between exosomes and gynecological malignant tumor [J]. Journal of Practical Oncology, 2020, 34(6): 571-575.
[4]	HAN Renqiang, WU Ming, MIAO Weigang, LUO Pengfei, YU Hao, ZHOU Jinyi. Malignant tumor epidemiology in Jiangsu province,2016 [J]. Journal of Practical Oncology, 2020, 34(4): 291-297.
[5]	LIN Yuhua, NI Zhenhua, SUN Yipeng, BI Junjie, WANG Xiongbiao. Research progress on the relationship between SPDEF and malignant tumors [J]. Journal of Practical Oncology, 2020, 34(2): 185-188.
[6]	BAO Le, TANG Liping. Progress of the EphB6 receptor in malignant tumors [J]. Journal of Practical Oncology, 2020, 34(1): 83-87.
[7]	ZHANG Huiting, LOU Ge. Research progress in 3D cell culture model of ovarian cancer tumor microenvironment [J]. Journal of Practical Oncology, 2019, 33(6): 557-560.
[8]	LI Yafei, ZHANG Xiao, WANG Xuefei, WENG Mingjiao, WANG Tianzhen. Effect of RNA-binding protein Lin28 on the development of malignant tumors and its molecular mechanism [J]. Journal of Practical Oncology, 2019, 33(5): 456-460.
[9]	CHEN Hongbo, YU Zengrong, DING Xiaofan, XIAO Lin. Progress of correlation between bone marrow dose-volume parameters and acute hematologic toxicity in pelvic malignant tumor [J]. Journal of Practical Oncology, 2019, 33(4): 361-366.
[10]	ZHANG Maoxiang,SUN Huixin,SONG Bingbing. Analysis of the incidence and mortality of malignant tumors in Daoli District,Harbin,2008—2012 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 261-265.
[11]	FU Yanli, YU Yang, WEI Wei, ZOU Jingjing, SUN Xiang. Study on predicting the cervical cancinogenesis by high-risk human papillomavirus load and the unbalanced expression of Th1/Th2 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 533-537.
[12]	YI Qingting, ZHANG Hongjun, JIANG Tao, FU Jialei, HUA Mingtao. Reversal effect and mechanism of polyene phosphatidylcholine on oxaliplatin resistance of gastric cancer cells in a nude mouse model [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 385-390.
[13]	HAN Bangling,WANG Yimin,XUE Yingwei. Research progress in the relationship between neutrophils and malignant tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 349-352.
[14]	ZHOU Jie, CHEN Yu, CHEN Daozhen. Application of nanoparticles in photodynamic therapy of tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 245-249.
[15]	HOU Siyu, CHEN Xiuwei. The structure and function of JMJD2B protein and its progress in the development of malignant tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 250-253.

Research progress of community follow-up model for malignant tumors

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments